ArticleUnited European gastroenterology journal2013

CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis.

Maria K Magnusson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.